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Background: It was recently suggested that electron ﬂow into cyt c, coupled with ROS generation, oxidizes cyt c
Met80 to Met80 sulfoxide (Met-O) in isolated hearts after ischemia–reperfusion, and converts cyt c to a peroxi-
dase. We hypothesize that ischemia disrupts Met80-Fe ligation of cyt c, forming pentacoordinated heme Fe2+,
which inhibits electron transport (ET) and promotes oxygenase activity.
Methods: SS-20 (Phe-D-Arg-Phe-Lys-NH2) was used to demonstrate the role of Met80-Fe ligation in ischemia.
Mitochondriawere isolated from ischemic rat kidneys to determine sites of respiratory inhibition.Mitochondrial
cyt c and cyt c Met-O were quantiﬁed by western blot, and cristae architecture was examined by electron
microscopy.
Results: Biochemical and structural studies showed that SS-20 selectively targets cardiolipin (CL) and protects
Met80-Fe ligation in cyt c. Ischemic mitochondria showed 17-fold increase in Met-O cyt c, and dramatic
cristaeolysis. Loss of cyt c was associated with proteolytic degradation of OPA1. Ischemia signiﬁcantly inhibited
ET initiated by direct reduction of cyt c and coupled respiration. All changes were prevented by SS-20.
Conclusion: Our results show that ischemia disrupts the Met80-Fe ligation of cyt c resulting in the formation of a
globin-like pentacoordinated heme Fe2+ that inhibits ET, and converts cyt c into an oxygenase to cause CL per-
oxidation and proteolytic degradation of OPA1, resulting in cyt c release.
General signiﬁcance: Cyt c heme structure represents a novel target for minimizing ischemic injury. SS-20, which
we show to selectively target CL and protect the Met80-Fe ligation, minimizes ischemic injury and promotes ATP
recovery.© 2015 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria play a crucial role in cellular energy generation and
must respond to ever-changing metabolic challenges to meet cellular
energy demands. Under ischemic conditions, the deﬁciency of sub-
strates and oxygen inhibits mitochondrial respiration and prevents
ATP production. There is a rapid fall in tissue ATP content as a result of
decreased ATP production, reversal of the ATP synthase to hydrolyze
ATP, and continuous cellular energy expenditure. Timely reperfusion
is the only means to reduce necrotic cell death and prevent organ fail-
ure. However, reperfusion does not result in full recovery of ATP content
[1,2]. Although much attention has been given to reperfusion injury
caused by the rapid release of reactive oxygen species (ROS) from ische-
mic mitochondria, other studies suggest that ischemia itself causes per-
manent injury to the mitochondrial electron transport chain (ETC) [1,3,
4]. Studies using mitochondria isolated from ischemic tissues havey,Weill CornellMedical College,
.shown signiﬁcant decreases in coupled respiration and increased elec-
tron leak at complexes I and III, suggesting an obstruction of electron
transport (ET) downstream of complex III, either at cytochrome (cyt)
c or complex IV [1,4–6]. The inhibition of complex IV (also known as cy-
tochrome c oxidase, COX) activity does not appear to result from func-
tional inactivation of the protein complex, but has been suggested to
be secondary to the loss of cardiolipin (CL) and cyt c [6–9].
Cyt c is the only component of the ETC that is not embedded in the
inner mitochondrial membrane (IMM). Cyt cmediates ET via reduction
and oxidation of its hexacoordinated heme iron (Fe) that is stabilized by
the axial ligands Met80 and His18 [10–12]. Electrostatic interaction be-
tween cyt c and CL anchors cyt c to the IMM and optimizes ET between
complex III and complex IV [13]. Interestingly, low ATP conditions favor
hydrophobic interaction between cyt c and CL [14,15], which is known
to disrupt the Met80-Fe ligation, resulting in a pentacoordinated heme
Fe [16–19]. The loss of the Met80-Fe ligation inhibits ET and converts
cyt c from an electron carrier to an oxygenase/peroxidase that can
cause CL peroxidation [12,20–23]. However, most of these studies
were done in cell-free in vitro systems, and the biological relevance of
this pentacoordinated cyt c is unclear. We hypothesize that ATP
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pentacoordinated heme Fe2+ accounts for inhibition of ET and CL per-
oxidation during ischemia.
Recent studies showed increase in oxidation of Met80 to the Met80-
sulfoxide (Met80-O), and loss of cardiolipin in the ischemic isolated
hearts after 30 min of reperfusion [24]. Since Met80 can only undergo
self-oxidationwhen it is not coordinating thehemeFe [19], these results
support ex vivo formation of pentacoordinated cyt c during ischemia–
reperfusion. Using normal isolated mitochondria, these investigators
proposed that electron ﬂow through cyt c, coupled with excessive ROS
production, is required for the oxidation of Met80 [24]. However, the
conditions required for cyt cMet-O formation and ROS formation in iso-
lated mitochondria are not the same [24], so it remains uncertain
whether inhibition of ET or excessive ROS, or both required for Met-O
formation and peroxidase activity.
Using an in vivo model of renal ischemia, we found signiﬁcant
inhibition of mitochondrial respiration and cristeolysis during ische-
mia alone [25,26]. Administration of SS-31, a mitochondria-targeted
antioxidant [27], protected cristae structure during ischemia, and
greatly accelerated ATP recovery upon reperfusion [25]. Although
we subsequently demonstrated that SS-31 inhibits peroxidase activity
of pentacoordinated cyt c in vitro [26], it is not clear whether this was
due to its antioxidant properties [27,28] or its ability to protect the cyt
c heme environment [26]. To resolve this issue, we decided to use an-
other mitochondria-targeted peptide, SS-20, which does not scavenge
ROS [27,28], to investigate the in vivo implications of pentacoordinated
cyt c. Similar to SS-31, SS-20 was found to protect cristae architecture,
prevent cyt c loss, promote recoverymitochondrial respiration upon re-
perfusion, and preserve organ function [2], indicating the importance of
pentacoordinated cyt c in ischemic injury. We also found increased
Met-O cyt c formation during renal ischemia, which was prevented by
SS-20, lending support for the formation of pentacoordinated cyt c
in vivo. In addition, we show that SS-20 prevents degradation of OPA1
(Optic Atrophy 1), an essential IMS protein for maintenance of cristae
junctions on the IMM and prevention of cyt c release [29–31], thereby
suggesting that cyt c peroxidase activity might initiate catalytic degra-
dation chain reaction on the IMM.
2. Materials and methods
2.1. Chemicals
Phe-D-Arg-Phe-Lys-NH2 (SS-20) was provided by Stealth Pep-
tides Inc., Newton Centre, MA. Aladan (ald; 2-amino-4-(6-
(dimethylamino)naphthalen-2-yl)-4-oxobutanoic acid) was syn-
thesized by J. David Warren (Weill Cornell Medical College) from
commercially available 6-methoxy-2-acetonaphthone, as described in
our recent publications [13,26]. Phe-D-Arg-Ald-Lys-NH2 ([ald]SS-20)
was synthesized by Dalton Pharma Services (Toronto, Ontario,
Canada). 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC),
1,2-dihexanoyl-sn-glycero-3-phosphocholine (DHPC), and natural CL
from bovine heart (containing 90% 18:2 acyl chains) were obtained
from Avanti Polar Lipids Inc. (Alabaster, AL). Horse heart cyt c and all
other reagents were obtained from Sigma-Aldrich, (St. Louis, MO).
2.2. Animals
Adult male Sprague–Dawley rats (Charles River Laboratories Inter-
national, Inc., Wilmington, MA) weighing 250 to 300 g were used in
the study. Animals were housed in a light-controlled room with a
12:12-hour light-dark cycle and allowed free access to water and stan-
dard rat chow. Care of the rats before and during the experimental pro-
cedures was conducted in accordance with the policies of the National
Institutes of Health Guidelines for the Care and Use of Laboratory Ani-
mals. All protocols had received prior approval by the Cornell University
Institutional Animal Care and Use Committee.2.3. Rat model of renal ischemia–reperfusion injury
Adult male Sprague–Dawley rats (250 to 300 g) were anesthetized
with 90 mg/kg ketamine and 4 mg/kg xylazine. Bilateral renal ischemia
was induced by the application of nontraumatic microvascular clamps
around both left and right renal pedicles for 45 min, as described in de-
tail previously [25,26]. Sham-operated animalswere not subjected to is-
chemia. Animals were randomly assigned to the following groups:
sham-operated, ischemia with saline, or ischemia with SS-20. SS-20
(2 mg/kg) or saline was administered subcutaneously 30 min before
the onset of ischemia. Animals were sacriﬁced and kidneys harvested
right after ischemia.
2.4. Preparation of rat kidney mitochondria and mitoplasts
Mitochondria were isolated from normal rat kidneys or ischemic
kidneys as described previously [13]. Mitochondria were either used
immediately for respiration experiments or frozen at −80 °C until
time of use for experiments with once-frozen mitochondria. The integ-
rity of freshly isolatedmitochondria was demonstrated by observing no
effect of exogenously added 20 μM cyt c on mitochondrial respiration.
To preparemitoplasts, the outermembranes of fresh or once-frozenmi-
tochondria were removed by 45 minute exposure to 3.3 mg/ml digito-
nin on ice [13]. To remove electrostatically-bound cyt c, 300 mM KCl
was added and the mixture was centrifuged for 30 min at 14,000 ×g.
The supernatant was discarded, and the pellet was washed with
300 mM KCl and re-dissolved in wash buffer and stored on ice until
use. Only those mitoplast preparations that show an increase in mito-
chondrial respiration by 4-6 fold upon addition of 400 nM of exogenous
house heart cyt c were used.
2.5. Oxygen consumption
Oxygen consumption in freshly isolated mitochondria was mea-
sured as described previously [13,26]. 40 μg/ml of freshly isolatedmito-
chondria from normal animals was incubated with 400 μM ADP (state
2) at 37 °C for 1 min, then succinate (500 μM) (complex II substrate)
or glutamate/malate (500 μM each) (complex I substrates) was
added to initiate state 3 respiration. TMPD (N,N,N′,N′-tetramethyl-
p-phenylenediamine) (3 μM)/ascorbate (500 μM) system was used
to directly reduce cyt c in intact mitochondria. Mitochondrial respira-
tion was allowed to proceed to state 4. SS-20 was added to the mito-
chondria prior to onset of respiration studies. Mitochondria isolated
from Sham, ischemia, or ischemia/SS-20 animals were also subjected
to the same treatment but respiration was studied without addition of
SS-20. Since the rate of oxygen consumption in general state 3 consists
of ATP synthase-driven respiration (OXPHOS-driven) and nonspeciﬁc
proton leak-driven respiration (state 4), theﬁnal state 3 (OXPHOS-driv-
en respiration)was calculated as the difference between general state 3
and state 4. Respiratory control ratio was calculated as a ratio of general
state 3 to state 4.
Oxygen consumption in once-frozenmitochondria directly indicates
ET through mitochondrial respiratory complexes because once-frozen
mitochondria have permeable outer and inner mitochondrial mem-
brane and thereby, have no mitochondrial membrane potential. Succi-
nate (500 μM) was used to measure ET from complex II to complex IV.
TMPD (3 μM)/ascorbate (500 μM) was used to directly reduce cyt c
and initiate ET to COX.
Oxygen consumption in cyt c-deﬁcient mitoplasts was measured
with 40 μg of mitoplast in 1 ml of 20mMHepes buffer, pH 7.4, after ini-
tiating respiration with TMPD (250 μM)/ascorbate (5 mM) in the pres-
ence of antimycin (2 μM) to block complex III. SS-20 was added to the
mitoplasts before initiating respiration. After the initial low respiration
in mitoplasts, exogenous horse heart cyt c (400 nM) alone was added
to promote respiration. Alternatively, 60 μMCLwas also added together
with cyt c to block respiration through cyt c.
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To measure COX activity in cyt c-deﬁcient mitoplasts from sham, is-
chemia, or ischemia/SS-20 animals, 10 μg of mitochondria was mixed
with 20 μMmaximally reduced cyt c (with 20 μMascorbate) and oxida-
tion of cyt c was measured at 550 nm with reference wavelength at
570 nm. The reaction was done in respiration buffer [13] at room tem-
perature for 15 s.
2.7. Mitochondrial membrane potential
Mitochondrial potential was qualitatively assessed by measuring
quenching of TMRM ﬂuorescence signal (excitation/emission = 550/
575 nm) [32]. The ﬂuorescence of this lipophilic cation is quenched
when it is taken up by mitochondria, and restored when mitochondria
become depolarized. In brief, isolated mitochondria (0.3 mg) were
added to 2.0 ml of buffer (70 mm sucrose, 230 mm mannitol, 3 mm
HEPES, 2mmTris-phosphate, 5mmsuccinate, and 1 μmrotenone) con-
taining TMRM (0.4–2 μm). Mitochondrial potential was quantiﬁed by
quenching of the ﬂuorescent signal [27,33].
2.8. Western blot assays for cyt c, Met-O cyt c, and OPA1
Frozen mitochondria were homogenized and sonicated and then
added to RIPA buffer (Santa Cruz, Santa Cruz, CA). Homogenates
(10 μg) were suspended in loading buffer and subjected to a 4–15%
SDS-PAGE precast gel (Bio-Rad, Hercules, CA) electrophoresis. The re-
solved proteins were transferred to a PVDF membrane. For detecting
Met-O after electroblotting, membranes were incubated overnight
with anti-methionine sulfoxide (Abcam, Cambridge, MA), rabbit poly-
clonal IgG 1:500 in 5% milk/TBST) and then with secondary goat anti-
rabbit IgG-HRP (Vector, Burlingame, CA) (1:5000 in 5% milk) for 1 h.
For cyt c detection, the same membranes were stripped and incubated
for 2 h with anti-cyt c mouse monoclonal IgG (Abcam, Cambridge,
MA) and another hour with HRP-conjugated monoclonal goat anti-
mouse IgG (Dako, Carpinteria, CA). OPA1 was detected by overnight in-
cubationwith anti-OPA1 rabbit polyclonal IgG (Abcam, Cambridge,MA)
1:1000 in 5%milk followed by one hour incubationwith secondary goat
anti-rabbit IgG-HRP 1:5000 in 5%milk (Vector, Burlingame, CA). All pro-
tein bands were detected by chemiluminescence with Clarity™West-
ern ECL Substrate (Bio-Rad, Hercules, CA) and autoradiography. Bands
were evaluated for integrated density values using Image Lab™ Soft-
ware (Bio-Rad, Hercules, CA). All membranes were ﬁnally stained
with Coomassie blue to determine the amount of protein for normaliza-
tion of cyt c in each lane.
2.9. Preparation of liposomes and bicelles
Lipids in chloroform were combined in 12 × 75 mm glass tubes in
the ratios for forming liposomes and bicelles, as described previously
[13]. Liposomes contained either 150 μM CL: 150 μM POPC or 300 μM
POPC. Bicelles contained either 150 μM CL: 1500 μM POPC: 4500 μM
DHPC or 1500 μM POPC: 4500 μM DHPC. The solvent was evaporated
slowly under N2 gas (TechAir, Naugatuck, CT, USA), and the resulting
lipid ﬁlm was rehydrated in an aqueous solution of 20 mM HEPES
pH 7.4 or deuterated water (D2O) buffered with 5 mM Na2PO4 and ti-
trated with HCL to a ﬁnal pH of 6.5 (for NMR studies). The resulting
multilamellar vesicles were vortexed lightly, and sized into small
unilamellar vesicles by 25min of heated bath sonication (Solid State Ul-
trasonic FS-9, 40 kHz, Fischer Scientiﬁc). Bicelles were not sonicated. All
liposomes and bicelles were cooled to ambient temperature before use.
2.10. Interaction of [ald]SS-20 and SS-20 with CL
To investigate if SS-20 interacts with CL, we incorporated a polarity-
sensitive ﬂuoroprobe (aladan) into SS-20 [13] (Supplementary Fig. 1).The ﬂuorescence emission spectrum of aladan (λex= 360 nm)was ob-
tained with 2 μM [ald]SS-20 in H2O, or after the addition of 10 μMPOPC
or POPC:CL (SPECTRAmax GeminiXPS, Molecular Devices, Sunnyvale,
CA). The interaction of SS-20 with CL was conﬁrmed by measurement
of changes in turbidity caused by the formation of a peptide-CL complex
via right-angle scattering at λ= 350 nm (Hitachi F-4500 Fluorescent
Spectrophotometer).
2.11. NMR analysis of SS-20 and CL interaction
NMR experiments were collected on a Bruker Avance III 500 MHz
NMR spectrometer equipped with a 5 mm broad-band with z-
gradient pulse ﬁeld gradients. The variable temperature unit was cali-
brated using a thermocouple placed inside a ﬁlled NMR tube within
the probe. The chemical shifts were referenced with 4,4-dimethyl-4-
silapentane-1-sulfonic acid (DSS) as an internal reference. Chemical
shifts of aromatic amino acids in SS peptideswere previously character-
ized [13]. NMR SS-20-lipid binding experiments were carried out using
bicelles containing either 150 μM TOCL: 1500 μM POPC: 4500 μMDHPC
or 1500 μM POPC: 4500 μMDHPC in 5 mM sodium phosphate adjusted
to pH 6.5 (uncorrected for isotope shifts) using 2HCl. Bicelles are small
lipid bilayers that form disk-like particles in solution. They are com-
posed of long chain lipids, which form a planar surface surrounded by
short chain lipids coating the edges. The small size of these bicelles al-
lows proteins/peptides to be analyzed by solution NMR, providing
good spectral characteristics (~21 kDa for POPC/DHPC q = 0.15 to
0.3) [13,34]. POPC/DHPC bicelles have been demonstrated to best ap-
proximate biological lipids in membrane protein crystallography stud-
ies and NMR studies [13]. The proton assignment for free SS-20 was
determined using 1DNMR. The phenylalanine (Phe) peakwas observed
between 7.4 and 7.2 ppm, in a region where POPC and CL are known to
have no peaks [13]. NMR data were processed and analyzed using Top-
spin 2.1 (Bruker Corporation) and MestReNova (Mestrelab Research
S.L., Santiago de Compostela, Spain).
2.12. Interaction of [ald]SS-20 with cyt c-deﬁcient mitoplasts, mitochon-
dria, puriﬁed cyt c, and cyt c in the presence of CL
To determine if SS-20 can interact with endogenous CL inmitochon-
dria, we measured the ﬂuorescence emission spectra of [ald]SS-20 after
addition of mitoplasts or frozen mitochondria (~40 μg/ml). To deter-
mine if [ald]SS-20 interacts with cyt c in the presence of CL, 2 μM
[ald]SS-20 was added to a mixture of 2 μM cyt c and 10 μM POPC:CL li-
posomes. The interaction between [ald]SS-20 and cyt c alone was in-
cluded to see if the peptide would interact directly with cyt c in the
absence of CL. The ﬂuorescence emission spectrum of [ald]SS-20
(λex=360 nm)was obtained using the SPECTRAmax GeminiXPS (Mo-
lecular Devices, Sunnyvale, CA).
2.13. Interaction of SS-20 with cyt c in the presence of CL
The interaction of SS-20 with cyt c in the presence of CL was exam-
ined by circular dichroism performed with an AVIA 62 DS spectropho-
tometer equipped with a sample temperature controller. The CD
spectrum of the Soret region (370–450 nm) was recorded with 10-mm
path length cells containing 20 mM Hepes, pH 7.4, and 10 μM cyt c, in
the presence or absence of 30 μg/ml CL and 10 μM SS-20. The maximum
lipid concentration was kept low to avoid spectral distortions due to ex-
cessive light scattering. All measurementswere done at 25 °C. All spectra
were corrected for background, and theﬁnal spectrum shown represents
the average of at least three experiments.
2.14. Peroxidase activity of cyt c in the presence of CL
The effect of SS-20 on CL-induced cyt c oxygenase/peroxidase activ-
ity was determined using the Amplex Red assay without the addition of
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(30 μM) for 1 min in 200 μl HEPES (pH 7.5) in the absence or presence
of 10 μM H2O2 and 50 μM Amplex Red reagent, and the reaction was
allowed to proceed for an additional 5 min. For some experiments
1 mM CaCl was incubated together with cyt c and CL prior to the addi-
tion of 10 μMH2O2 and 50 μMAmplex Red reagent, to investigate effects
of calcium on peroxidase activity. The continuous time course datawere
obtained using a microplate spectroﬂuorometer (Molecular Devices,
Sunnyvale, CA).
2.15. Cyt c reduction and electron transport in the presence of CL
Cardiolipin is known to inhibit the reduction of cyt c [13–15]. Cyt c
(20 μM)was preincubated with CL, in the absence or presence of differ-
ent concentrations of SS-20, for 1 min. Cyt c reduction was initiated by
the addition of 500 μM glutathione. The rate of cyt c reduction was cal-
culated from the slope of (A550–A570) over 2 min (SPECTRAmax 190,
Molecular Devices, Sunnyvale, CA). The ability of SS-20 to promote elec-
tron transfer in the ETC was determined by measurement of oxygen
consumption in mitoplasts (Hansatech Instruments, Norfolk, UK) [13].
Respiration was initiated in mitoplasts (40 mg) with TMPD (250 μM)/
ascorbate (5 mM). Antimycin (2 μM) was added to block complex III.
As these mitoplasts are deﬁcient in cyt c, exogenous cyt c (400 nM)
was added to promote respiration.
2.16. H2O2 release in mitochondria
The rate of mitochondrial H2O2 generation was determined in sepa-
rate experiments where mitochondria were incubated with succinate
(5 mM) and no ADP for 15 min. The reaction was stopped and centri-
fuged at 14,000 ×g, 4 °C, for 5 min. The supernatant was collected and
the amount of H2O2 released determined using the Amplex Red assay
(λex/λem= 570/585 nm).
2.17. Electron microscopy
Kidney tissues were ﬁxed in 4% paraformaldehyde, postﬁxed in 1%
osmium tetroxide, dehydrated in graded alcohols, and embedded in
Epon. Ultrathin sections (200 to 400 Å)were cut on nickel grids, stained
with uranyl acetate and lead citrate, and examined using a digital elec-
tron microscope with a 2.0 CCD camera (JEOL USA JEM-1400, Peabody,
MA).
2.18. Statistical analysis
All results are expressed as mean ± SEM. Statistical analyses were
carried out using one-way ANOVA analysis with multiple comparisons
or t-test (GraphPad Software, Inc., San Diego, CA).
3. Results
3.1. SS-20 preserves mitochondrial ET through cyt c in ischemic
mitochondria
To determine the effect of ischemia on mitochondrial respiration
upon reperfusion, we isolated kidney mitochondria from rats after
45 min ischemia. Mitochondrial respiratory activity was initiated from
different respiratory complexes ex vivo. State 3 respiration (coupled to
ATP synthesis) was signiﬁcantly inhibited in ischemic mitochondria in-
duced by complex I substrates (Fig. 1A) or complex II substrates
(Fig. 1B) compared to sham controls. In contrast, state 4 respiration
(uncoupled from OXPHOS) was unchanged (Fig. 1C and D), suggesting
that in contrast to mitochondria isolated after reperfusion [4], proton
leak is not increased in ischemic mitochondria. Ischemia signiﬁcantly
reduces O2 consumption induced by direct reduction of cyt c with
N,N,N,N-tetramethyl-p-phenylenediamine (TMPD) (Fig. 1E) withoutaltering COX activity (Fig. 1F), indicating that cyt c is the site of ET inhi-
bition during ischemia. Importantly, ischemic mitochondria from the
SS-20 treated group demonstrated considerable improvement of ET
function, with signiﬁcant improvement in state 3 respiration. There
was no effect on state 4 respiration, showing that SS-20 does not uncou-
ple mitochondrial respiration (Fig. 1A–D). TMPD-induced respiration
was also protected in SS-20-treated animals, without increasing the ac-
tivity of COX (Fig. 1E and F), suggesting that SS-20 selectively targets cyt
c and prevents ET dysfunction during ischemia.
3.2. SS-20 prevents oxidative modiﬁcation of cyt c and cyt c release during
ischemia
Mitochondria from sham animals revealed very lowMet-O cyt c for-
mation, while 45min ischemia alone induced a 17-fold increase inMet-
O cyt c (Fig. 2A). Treatmentwith SS-20 signiﬁcantly reducedMet-O cyt c
formation (Fig. 2A). Increase in Met-O cyt c formation correlated well
with cyt c release from mitochondria and SS-20 completely prevented
the loss of mitochondrial cyt c (Fig. 2B).
3.3. SS-20 prevents cristaeolysis and degradation of OPA1 during ischemia
To better understand howcyt c is released frommitochondria during
ischemia, we examined mitochondrial structure using transmission
electron microscopy. We focused on mitochondria in the proximal tu-
bules because they rely solely on mitochondria for ATP synthesis as
they lack glycolytic capability [35–37]. In sham samples, mitochondria
were elongated with densely-packed cristae membranes (Fig. 2C).
45min of ischemia resulted in large, roundedmitochondriawithmatrix
swelling and disappearance of cristae structures. Outer mitochondrial
membranes remained mostly intact. Mitochondrial swelling was dra-
matically reduced by SS-20 treatment, and matrix density and cristae
morphology were largely preserved.
Cyt c is normally sequestered in the intracristae space (ICS) due to
the presence of cristae junctions on the IMM. OPA1 is a protein that is
located at cristae junctions and serves to maintain cristae morphology
[29–31]. Loss of OPA1 causes disorganization of cristae membranes
and loss of cyt c. Proteolytic degradation of OPA1 is induced by dissipa-
tion of mitochondrial membrane potential and leads to loss of cristae
morphology [31,38]. It is not known if ischemia will induce proteolysis
of OPA1 and cause cyt c release. We examined the various isoforms of
OPA1 using western blot. With ischemia, there was increased process-
ing of the long-form OPA1 (~110 kDa) (L-OPA1) to lower molecular
weight bands at ~100 kDa (intermediate form of OPA1, I-OPA1) and
~85 kDa (S-OPA1) (Fig. 2D). Treatmentwith SS-20 signiﬁcantly reduced
the processing of L-OPA1 (Fig. 2D and E), which also correlates with the
ability of SS-20 to preserve cristae structure (Fig. 2C).
3.4. SS-20 preserves Met80-Fe ligation and protects ET properties of cyt c
while inhibiting peroxidase activity
The ability of SS-20 to protect ET through cyt c and preventMet80 ox-
idation suggests that SS-20 might act by protecting the Met80-Fe liga-
tion during ischemia. Previous studies have shown that low ATP
conditions promote hydrophobic interaction between cyt c and CL,
which disrupts the Met80-Fe ligation and results in a more open heme
crevice [16,17,39,40]. The Met80-Fe ligation can be monitored by circu-
lar dichroism [41]. The addition of CL to cyt c results in loss of the nega-
tive Cotton peak at 419 nm and this is restored by the addition of SS-20
in a 1:1 ratio with cyt c (Fig. 3A), providing evidence that SS-20 can pro-
tect the Met80-Fe coordination in the presence of CL and preserve the
closed heme crevice. Disruption of the Met80-Fe bond lowers the
redox potential of cyt c and decreases ET rate through cyt c [20,21].
SS-20 dose-dependently restored the ability of glutathione to reduce
Fe3+ cyt c in the presence of CL, while it had no effect on native cyt c
(Fig. 3B). In mitoplasts, addition of CL also inhibited O2 consumption
Fig. 1. SS-20 preserves mitochondrial ET through cyt c in ischemic mitochondria. A–B, Ischemia compromises state 3 respiration in rat kidney mitochondria when electron transport is
initiated by glutamate/malate (G/M) (Complex I) (A) or succinate (Complex II) (B). SS-20 signiﬁcantly restores respiration in each case. C–D, Ischemia does not change state 4 respiration
in rat kidney mitochondria when initiated by complex I (C) or complex II (D) substrates. SS-20 has no effect. E, Ischemia reduces state 3 respiration initiated by direct reduction of cyt c
using TMPD. SS-20 restores respiration. F, Ischemia does not change the ability of COX (Complex IV) in isolated mitoplasts to oxidize exogenous cyt c, and SS-20 has no effect. Error bars
represent SEM (n= 4–10) **P = 0.01; ***P = 0.001.
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(Fig. 3C). Addition of SS-20 to that system signiﬁcantly prevented the
inhibitory action of CL on cyt c reduction (Fig. 3C).
Globin-like pentacoordinated cyt c can react with oxygen or H2O2 to
promote oxygenase/peroxidase activity of that enzyme [22,23,26].
Calcium, which is elevated during ischemia, was recently shown to
potentiate peroxidase activity of cyt c [26]. We determined cyt c
oxygenase/peroxidase activity using the Amplex Red assay. Addition
of CL to cyt c in the absence of H2O2 elicits oxygenase activity that is
dose-dependently inhibited by SS-20 (data not shown). Addition of
H2O2 increased the rate of the reaction, and SS-20 inhibited this perox-
idase activity with similar EC50 (~30 μM) either in the presence or ab-
sence of calcium (Fig. 3D and E).
3.5. SS-20 binds selectively to mitochondrial CL and interacts with cyt c
To understand how SS-20 protects the heme environment of cyt c in
the presence of CL, we synthesized a ﬂuorescent analog of SS-20 by
substituting Phe3 with aladan (Ald), a polarity-sensitive ﬂuorescent
amino acid [42], resulting in [ald]SS-20 (H-Phe-D-Arg-Ald-Lys-NH2)
(Supplemental Fig. 1). Addition of liposomes containing POPC and CL,
but not POPC alone, dramatically increases ﬂuorescence of [ald]SS-20
and blue-shifts the λmax from 535 nm to 465 nm, demonstrating a se-
lective hydrophobic interaction between [ald]SS-20 and CL-containing
membranes (Fig. 4A). Right-angle light scattering also conﬁrms speciﬁc
interaction between SS-20 and CL, and suggests maximal interaction at
an SS-20:CLmolar ratio of ~2 (Fig. 4B). 1D 1HNMRdemonstrates specif-
ic interaction between SS-20 and bicelles containing 2.5% CL, where the
side chain resonances of Phe (7.2–7.4 ppm) are suppressed (Fig. 4C),
suggesting penetration of the aromatic rings into the lipid bilayer. To
determine whether SS-20 can interact with endogenous CL in mito-
chondria, [ald]SS-20 was added to once-frozen mitochondria or cyt c-
deﬁcient mitoplasts, and a similar blue-shift of the λmax of [ald]SS-20
was observed (Fig. 4D). Surprisingly, the increase in ﬂuorescence inten-
sity of [ald]SS-20 was signiﬁcantly greater with cyt c-depletedmitoplasts (Fig. 4D and E), suggesting that the ﬂuorescence of [ald]SS-
20 in frozen mitochondria may be partially quenched by the cyt c
heme. To conﬁrm this idea, we demonstrated that the ﬂuorescence in-
tensity of [ald]SS-20 is quenched by cyt c in the presence of CL
(Fig. 4F), though addition of cyt c alone does not change the ﬂuores-
cence spectrum of [ald]SS-20. Therefore, our data show that in the pres-
ence of CL, SS-20 is able to penetrate into the hemeenvironment of cyt c.3.6. SS-20 promotes efﬁciency of ET and inhibits ROS formation in isolated
mitochondria
Low ATP conditions are known to promote hydrophobic interaction
between cyt c and CL and inhibit cyt c reduction. Under conditions nor-
mally used for isolatingmitochondria,mitochondrial ATP levels are very
low, and this may impact measurements of mitochondrial respiration
ex vivo. These conditions also reﬂect in vivo conditions of ischemicmito-
chondria subjected to reperfusion, except that cyt c concentrations may
be normal. Addition of SS-20 to freshly isolated intact mitochondria
dose-dependently increases state 3O2 consumption initiated from com-
plexes I or II (Fig. 5A and C) and respiratory control ratio (RCR) (Fig. 5B
and D), supporting our hypothesis that SS-20 promotes efﬁciency of the
ETC at the level downstream of complexes I and II, and improves cou-
pling of ET to OXPHOS. Importantly, tominimize the effect ofmitochon-
drialmembrane potential on ET,we used once-frozenmitochondria and
demonstrated that SS-20 dose-dependently increases O2 consumption
induced by succinate (Fig. 5E). Finally, the ability of SS-20 to promote
respiration after direct reduction of cyt c with TMPD (Fig. 5F) without
stimulating COX activity (Fig. 5G) identiﬁes cyt c as a site of SS-20 activ-
ity. We further show that SS-20 does not increase mitochondrial respi-
ration by uncouplingmitochondria as measured by TMRM ﬂuorescence
(Fig. 5H). By improving ET at the level of cyt c, SS-20 also prevents
electron backﬂow and reduces H2O2 production in isolated mitochon-
dria, comparable to that achieved by the uncoupler FCCP (carbonyl
cyanide-4-(triﬂuoromethoxy)phenylhydrazone (Fig. 5I).
Fig. 2. SS-20 prevents oxidative modiﬁcation of cyt c, cyt c release, and cristaeolysis during ischemia. A, Representative western blot and quantiﬁcation of Met-O cyt c formation in mito-
chondria from rat sham, or ischemic kidneys pre-treatedwith saline or SS-20. Bands forMet-O cyt c and cyt c are identiﬁed. B, Quantiﬁcation of cyt c in isolatedmitochondria from sham or
ischemic kidneys of rats, pretreatedwith saline or SS-20. C, Representative TEM images ofmitochondria and cristaemorphologyunder either shamor ischemic conditions pre-treatedwith
saline or SS-20. D–E, Representativewestern blot (D) and quantiﬁcation (E) of OPA-1 isoforms from isolatedmitochondria. Acute ischemia induces signiﬁcant cleavage of longest form (L;
~110 kDa) into an intermediate (I; ~95 kDa) form. SS-20 partially prevents this cleavage. Error bars represent SEM (n= 4) **P = 0.01; ***P = 0.001.
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It is now clear that mitochondrial damage incurred during ischemia
prevents rapid recovery of ATP upon reperfusion and extends ischemic
injury. Ischemia is known to directly inhibit the ETC [8,9], and previous
studies suggest that this inhibition is downstream of complex III, either
at cyt c or complex IV. In this study, we have identiﬁed cyt c as an early
victim of ischemia, and shown that ischemia-induced changes in cyt c
structure and function account for the inhibition ofmitochondrial respi-
ration, cristaeolysis, and cyt c release during ischemia (Fig. 6). The re-
duction in ATP during ischemia promotes hydrophobic interaction
between cyt c and CL [26,27], resulting in disruption of theMet80-Fe co-
ordination and formation of a globin-like pentacoordinated cyt c that is
mostly in the ferrous (Fe2+) state during ischemia. This ferrous state of
pentacoordinated cyt c predisposes the oxidation of Met80 to Met80-O
[38], and inhibits the re-ligation of Met80 to heme Fe [39,40]. Thereduction potential of pentacoordinated cyt c is signiﬁcantly lower
than native cyt c, and this inhibits the reduction of cyt c by complex III
in the ETC [15,16]. These changes can account for the inhibition of mito-
chondrial respiration when ischemic mitochondria are exposed to re-
perfusion conditions. Displacement of Met80 from the heme Fe2+
converts cyt c from an electron carrier to an oxygenase that can oxidize
cardiolipin, resulting in cristae degradation and detachment of cyt c
from the IMM [17–19]. The ultimate release of cyt c from the ICS occurs
when OPA1 is degraded during ischemia, as OPA1 plays a major role in
establishing cristae junctions and keeping the cyt c within the ICS [41].
Thus damage to cyt c heme structure, together with loss of CL and cyt
c, explain the slow and incomplete recovery of mitochondrial ATP pro-
duction upon reperfusion.
SS-20 is a cell-permeable, mitochondria-targeting tetrapeptide that
belongs to the Szeto-Schiller (SS) peptides [42,43]. In this study we
show that SS-20 can prevent all downstream events caused by the
Fig. 3. SS-20 preserves Met80-Fe ligation and protects ET properties of cyt cwhile inhibiting peroxidase activity. A, Circular dichroismwas carried out to demonstrate that SS-20 recovered
the effect of CL on the negative 418 nm Cotton peak in the Soret spectrum of cyt c. B, SS-20 promotes reduction of cyt c in the presence of CL. Addition of CL inhibited glutathione-induced
cyt c reduction by about 60%. SS-20 had no effect on the reduction of cyt c in the absence of CL, but dose-dependently rescued the inhibition caused by CL. C, SS-20 promotes oxygen con-
sumption inmitoplasts in the presence of exogenous cyt c and excess CL. Mitochondrial respiration was initiated by direct reduction of cyt cwith TMPD/ascorbate. SS-20 had no effect on
O2 consumption in the presence of added exogenous cyt c alone, but restored O2 consumption inhibited by the addition of CL. D, SS-20 dose-dependently inhibits cyt c peroxidase activity
induced by CL (EC50 = 9.7 ± 2.5 μM). E, SS-20 dose-dependently inhibits cyt c peroxidase activity potentiated by Ca2+. Error bars represent SEM (n= 5–9) ***P = 0.001.
Fig. 4. SS-20 binds selectively tomitochondrial CL and interactswith cyt c. A, Representativeﬂuorescence emission spectrumof control [ald]SS-20 and in thepresenceof POPC liposomes or
POPC-CL liposomes. CL-containing liposomes induce blue shift from 535 nm to 465 nm, but POPC liposomes do not. B, SS-20 dose dependently increases light scattering of POPC-CL lipo-
somes, but not POPC liposomes. C, Representative 500 MHz 1H-NMR of the aromatic region (7.5–7.1 ppm). From top, as indicated: (1) SS-20 aromatic protons of phenylalanine (7.4–
7.2 ppm); (2) POPC does not substantially affect aromatic proton peaks; (3) CL remodels and broadens the aromatic protons of SS-20. Phospholipids themselves contribute no peaks in
this range. D, [ald]SS-20 interacts with both once-frozen mitochondria and cyt c-depleted mitoplasts from rat kidney. E, Quantitative analysis of the intensity of the 465 nm peak of
[ald]SS-20 in cyt c-depleted mitoplasts and once-frozen mitochondria. F, [ald]SS-20 interacts with cyt c in the presence of CL. Representative ﬂuorescence emission spectrum of
[ald]SS-20 alone, and in the presence of cyt c, CL, and a cyt c+ CL mix. Error bars represent SEM (n= 6) ***P = 0.001.
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Fig. 5. SS-20 promotes efﬁciency of ET and inhibits ROS formation in isolated mitochondria. A–B, SS-20 improves glutamate/malate-driven state 3 respiration (A) and RCR (B) in freshly
isolatedmitochondria. C–D, SS-20 improves succinate-driven state 3 respiration (C) and RCR (D) in freshly isolatedmitochondria. E, SS-20 dose-dependently increases O2 consumption in
the presence of succinate in once-frozenmitochondria. F, SS-20 improves O2 consumption during direct reduction of cyt c by TMPD in once-frozenmitochondria. G, SS-20 does not affect
COX activity of isolated mitoplasts. H, SS-20 does not affect potential-driven uptake of TMRM into freshly isolated mitochondria. I, Both SS-20 and FCCP reduce the formation of H2O2 in
isolated mitochondria. Error bars represent SEM (n = 6–7) **P = 0.01; ***P = 0.001.
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and structural evidence that SS-20 interacts with CL with high selectiv-
ity and afﬁnity. In addition, SS-20 interacts with endogenous CL in iso-
lated mitochondria and mitoplasts. Furthermore, our results with the
ﬂuorescent analog ([ald]SS-20) indicate that SS-20, when interacting
with CL, can penetrate into the heme environment of cyt c and protect
the Met80-Fe ligation. This is further supported by circular dichroism
studies showing that SS-20 protects the negative Cotton peak of cyt c
against CL-induced damage, thus preserving the stability of the Fe-
Met80 coordination and π–π interaction within the heme environment
[44]. When administered to rats prior to onset of ischemia, SS-20 signif-
icantly protected coupled respiration in ischemic mitochondria studied
ex vivo, including O2 consumption initiated by direct reduction of cyt c
with TMPD. These results conﬁrm that ischemia disrupts the heme liga-
tion in cyt c and compromises the recovery of mitochondrial ATP syn-
thesis upon reperfusion. Of particular interest is our ﬁnding that SS-20
can even increase coupled respiration and reduce H2O2 emission in nor-
mal mitochondria. It appears that the approach normally used to study
isolated mitochondria ex vivo actually simulates the condition of ische-
mic mitochondria upon reperfusion. Isolated mitochondria arerelatively depleted of ATP and they are then studied under atmospheric
oxygen. In those conditions, even though cyt c content is preserved,
they are most likely in a hydrophobic interaction with CL and thus ex-
hibit inhibited electron transfer. The SS-20-potentiated oxygen con-
sumption with glutamate/malate (complex I substrates) is similar to
those obtained with succinate (complex II substrate), supporting our
conclusion that SS-20 stimulates ET downstream of complexes I and II.
Furthermore, SS-20 promotes TMPD-induced respiration directly
through cyt cwithout affecting COX activity, suggesting that SS-20 opti-
mizes ET through cyt c.
Substantial in vitro data show that hydrophobic interaction between
cyt c and CL disrupts the Met80-Fe ligation [32,33,45], but the signiﬁ-
cance of such hydrophobic interaction in vivo has not been demonstrat-
ed. Evidence for disruption of the cyt c Met80-Fe ligation during
ischemia comes from our ﬁnding of a 17-fold increase in Met-O cyt c.
Cyt c has two evolutionarily conserved methionine residues (Met65
and Met80), but Met80 is the preferred site of sulfoxide formation [1,
38]. Met-O formation is favored with Fe2+ compared to Fe3+ cyt c [1,
38], and cyt c is likely to be in the Fe2+ state during ischemia as COX
is inhibited due to decline in oxygen [46–48]. Interestingly, cyt c
Fig. 6. Schematic diagram illustrating mitochondrial dysfunction in ischemic injury. De-
crease in ATP during ischemia promotes hydrophobic interaction of cyt cwith CL, forming
the globin-like pentacoordinated Fe2+ cyt c. This inhibits ET through cyt c and converts
this electron carrier into an oxygenase/peroxidase that can oxidize lipids and proteins
on the IMM and in the IMS. Oxidation of cardiolipin and proteolytic degradation of
OPA1 promote cristaeolysis and cyt c release, further diminishing the activity of themito-
chondrial ETC and ATP synthesis. SS-20 protects hexacoordination of cyt c during ische-
mia, supports ET through cyt c, and prevents oxygenase/peroxidase activity.
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but the increase was only 2-fold [1]. This much smaller increase in
Met-O cyt c during reperfusion may correlate with the recovery of
COX activity with the re-introduction of O2.
It was previously thought that excessive matrix ROS is necessary for
cyt cMet-O formation [1], but it is unclear howmatrix ROS can oxidize
cyt c in the ICS. Interestingly, cyt c Met-O formation in isolated mito-
chondria was induced by inhibition of COX with azide, but not by inhi-
bition of complex III with antimycin [1]. These results would suggest
that ROS release is not required since azide did not increase ROS emis-
sion [1]. Rather, it would suggest that accumulation of Fe2+ cyt c is re-
quired for Met80 oxidation. Furthermore, it should be pointed out that
conditions used in ex vivomitochondrial respiration studies (low ATP)
promote pentacoordination of cyt c [11]. This is consistentwithprevious
ﬁndings that self-oxidation of Met80 of cyt c occurs by its heme andmo-
lecular oxygen when Met80 dissociates from the heme Fe in a reducing
environment [38]. Our results demonstrate that Met-O cyt c can be
formed during ischemia when there is unlikely to be excessive ROS for-
mation, and it indicates the generation of pentacoordinated Fe2+ cyt c
in vivo.
Displacement of Met80 from the heme Fe results in opening of the
heme crevice and the high spin Fe2+ can react with molecular oxygen
to form an oxygenase that can oxidize CL without H2O2 [17,18]. In addi-
tion, the restoration of Fe3+ cyt c upon reperfusion can be oxidized by
H2O2 to oxyferryl heme, forming the so-called peroxidase compound
I-type intermediate, a highly reactive oxidant that can react with pro-
teins and lipids on the IMM and in the IMS [38,49]. Peroxidase activity
and oxidized CL can be readily detected with [cyt c/CL] complexes
in vitro and with isolated mitochondria [18,19]. Cyt c oxygenase or per-
oxidase activity has not been demonstrated in vivo, but the presence of
Met-O cyt c supports the existence of oxygenase/peroxidase activity,
which can account for cristae degradation. Degeneration of mitochon-
drial morphology, especially cristaeolysis, is commonly observed in is-
chemic mitochondria [3,19,24]. Peroxidized cardiolipin can further
elicit a free radical chain reaction even without further ROS production.
In addition, peroxidized CL can oxidize Fe2+ cyt c and cause heme deg-
radation and aggregation [50]. By protecting the heme ligation, SS-20
was able to prevent cristeolysis and maintain mitochondrial cristae ar-
chitecture during ischemia.Besides CL, OPA1 localized on the IMM [31,51], is thought to be re-
sponsible for cristae assembly, remodeling, and cyt c containment
within the ICS [41]. Silencing of OPA1 in mammalian cells caused mito-
chondrial swelling with disintegrated cristae structures [21,52]. Al-
though long (L) and short (S) isoforms of OPA1 are both present on
the IMM [23,31,53], depletion of L-OPA1 destabilizes cristae formation,
promotes cyt c release and inhibits mitochondrial bioenergetics [23,
31,53,54]. Importantly, oxidative stress was recently shown to produce
sequential cleavage of L-OPA1 to an intermediate OPA1 and later to the
S-OPA1 form, resulting in cristae remodeling and release of cyt c from
the ICS [55,56]. Our study is the ﬁrst to demonstrate a correlation be-
tween oxidative stress in the ICS, degradation of L-OPA1, and loss of mi-
tochondrial cyt c in vivo. SS-20 was able to inhibit proteolytic
degradation of L-OPA1 during ischemia and prevent loss of mitochon-
drial cyt c.
Although ischemia–reperfusion injury is commonly thought to be
due to mitochondrial oxidative stress associated with reperfusion,
we have identiﬁed cyt c as an early victim of ischemic injury, and
the damage to its heme ligation sets up a feed-forward chain of
events that inhibits the mitochondrial ETC and prevents recovery
of mitochondrial function upon reperfusion. This has led us to intro-
duce a new therapeutic strategy that emphasizes protection of the
heme environment of cyt c to optimize electron transfer, minimize
ROS production, and prevent the conversion of this electron carrier
into a catalytic oxidant.5. Translational relevance
After the onset of ischemia, timely reperfusion is essential to salvage
viable tissue. The ability of reperfusion to restore mitochondrial bioen-
ergetics is dependent on the duration of ischemia, as ischemia causes
permanent injury to the mitochondrial ETC. This study has identiﬁed
cyt c as an early victim of ischemia, and the Met80-Fe ligation was spe-
ciﬁcally demonstrated to be the cause of a cascade of downstream
events that limit the recovery of mitochondrial function upon reperfu-
sion. By protectingMet80-Fe ligation in ischemia, SS-20 was able to pre-
vent all downstream mitochondrial injuries and optimize recovery of
organ function [2]. SS-20 provides a novel strategy for mitochondrial
protection during ischemia and may be beneﬁcial in clinical indications
such as elective angioplasty, cardiovascular surgery, partial nephrecto-
my and transplantation.
Supplementary data to this article can be found online at http://dx.
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